{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:35:40Z","timestamp":1792427740893,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.07.012","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T23:04:44Z","timestamp":1658444684000},"page":"5095-5102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008\u20132019"],"prefix":"10.1016","volume":"40","author":[{"given":"Manjiri","family":"Pawaskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneth","family":"Gil-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Irene Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rey-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieralessandro","family":"Lasalvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.07.012_b0005","article-title":"Varicella epidemiology in Latin America and the Caribbean","author":"\u00c1vila-Ag\u00fcero","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.07.012_b0010","unstructured":"Kota, V and Grella, MJ. Varicella (Chickenpox) Vaccine, in StatPearls. 2021, StatPearls Publishing: Treasure Island (FL)."},{"issue":"12","key":"10.1016\/j.vaccine.2022.07.012_b0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/14760584.2017.1394843","article-title":"Varicella and herpes zoster vaccine development: lessons learned","volume":"16","author":"Warren-Gash","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"42","key":"10.1016\/j.vaccine.2022.07.012_b0020","doi-asserted-by":"crossref","first-page":"1900233","DOI":"10.2807\/1560-7917.ES.2019.24.42.1900233","article-title":"Burden of varicella complications in secondary care, England, 2004 to 2017","volume":"24","author":"Bernal","year":"2019","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.vaccine.2022.07.012_b0025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","article-title":"Varicella vaccination - the global experience","volume":"16","author":"Wutzler","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.012_b0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s12889-019-6795-0","article-title":"Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review","volume":"19","author":"Arlant","year":"2019","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2022.07.012_b0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vaccine.2017.12.011","article-title":"Single-dose varicella vaccine effectiveness in Brazil: A case-control study","volume":"36","author":"Andrade","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.012_b0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14760584.2017.1247700","article-title":"Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination","volume":"16","author":"Avila-Aguero","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.07.012_b0045","article-title":"Documento de Posici\u00f3n de la SLIPE - Prevenci\u00f3n de Varicela en Am\u00e9rica Latina y el","author":"Force","year":"2017","journal-title":"Caribe"},{"issue":"10","key":"10.1016\/j.vaccine.2022.07.012_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2007.126243","article-title":"Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997\u20132005","volume":"93","author":"Quian","year":"2008","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.012_b0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2017.11.057","article-title":"Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil","volume":"36","author":"Scotta","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.012_b0060","first-page":"402","article-title":"How cost effective is universal varicella vaccination in developing countries?","volume":"31","author":"Paternina-Caicedo","year":"2013","journal-title":"A case-study from Colombia Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.012_b0065","unstructured":"Instituto Nacional de Salud. Protocolo de vigilancia en salud p\u00fablica: Varicela (c\u00f3digo: 831). 2017; Available from: https:\/\/www.hosdenar.gov.co\/images\/protoc_ficha_temas_consulta\/protocolos2020\/PRO_Varicela.pdf. Accessed: 2020 Jul 15."},{"key":"10.1016\/j.vaccine.2022.07.012_b0070","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (MSPS). Sismed - Sistema de informaci\u00f3n de precios de medicamentos. Reporte 2020-Q2. 2020; Available from: http:\/\/www.sispro.gov.co\/recursosapp\/app\/Pages\/Precios de Medicamentos - Circular 2 de 2012 Excel.aspx. Accessed: 2020 Sep 15."},{"key":"10.1016\/j.vaccine.2022.07.012_b0075","unstructured":"Departamento Administrativo Nacional de Estad\u00edsticas (DANE). Estad\u00edsticas vitales - EEVV. 2009; Available from: https:\/\/www.dane.gov.co\/files\/investigaciones\/fichas\/Estadisticas_vitales.pdf. Accessed: 2020 Jul 20."},{"key":"10.1016\/j.vaccine.2022.07.012_b0080","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Lineamientos para la gesti\u00f3n y administraci\u00f3n del programa ampliado de inmunizaciones. 2021; Available from: http:\/\/www.saludinfantilvalledelcauca.com\/uploads\/1\/3\/7\/8\/13787752\/lineamientos_nacionales_pai_2021.pdf. Accessed: 2021 July 10."},{"key":"10.1016\/j.vaccine.2022.07.012_b0085","unstructured":"Ministerio de Salud y de la Protecci\u00f3n Social. Coberturas de vacunaci\u00f3n departamentales 1998-2019. 2020."},{"key":"10.1016\/j.vaccine.2022.07.012_b0090","unstructured":"Instituto Nacional de Salud. Protocolo de vigilancia en salud p\u00fablica: Varicela (c\u00f3digo: 831). 2017."},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.012_b0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.07.012_b0100","doi-asserted-by":"crossref","first-page":"S658","DOI":"10.1016\/j.jval.2019.09.1365","article-title":"Pin124 Impact of Chickenpox Vaccination in Colombia 2014\u20132017","volume":"22","author":"Rey-Velasco","year":"2019","journal-title":"Value in Health"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.012_b0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.14482\/sun.33.3.10902","article-title":"Epidemiological situation of varicella at Casanare (Colombia), 2010\u20132014","volume":"33","author":"Aranguren Segura","year":"2017","journal-title":"Salud Uninorte"},{"issue":"4","key":"10.1016\/j.vaccine.2022.07.012_b0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1590\/S0021-75572009000400016","article-title":"Impact of vaccination against varicella on the reduction of the disease incidence in children and adolescents from Florianopolis","volume":"85","author":"Kupek","year":"2009","journal-title":"Brazil J Pediatr (Rio J)"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2022.07.012_b0115","article-title":"2476. Impact of the Vaccination Strategy on Varicella Burden Disease in Argentina. Open Forum","volume":"5","author":"Neyro","year":"2018","journal-title":"Infectious Diseases"},{"key":"10.1016\/j.vaccine.2022.07.012_b0120","unstructured":"Pujadas, A, et al. Varicela en un pa\u00eds del Cono Sur de Am\u00e9rica Latina. Situaci\u00f3n epidemiol\u00f3gica y estrategias de prevenci\u00f3n Per\u00edodo 2008\u20132018. Poster presented at X Congreso International de Infectolog\u00eda pedi\u00e1trica y vacunas (SADIP 2021, April 28-30, 2021), 2021."},{"key":"10.1016\/j.vaccine.2022.07.012_b0125","unstructured":"CDC. Chickenpox Vaccine Saves Lives and Prevents Serious Illness Infographic. 2014; Available from: https:\/\/www.cdc.gov\/chickenpox\/vaccine-infographic.html."},{"issue":"s2","key":"10.1016\/j.vaccine.2022.07.012_b0130","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing Varicella Epidemiology in Active Surveillance Sites\u2014United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J INFECT DIS"},{"issue":"6","key":"10.1016\/j.vaccine.2022.07.012_b0135","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/ciz305","article-title":"The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991\u20132016","volume":"70","author":"Wolfson","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.012_b0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.012_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"I, and Study Group for Varivax. Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.012_b0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1473-3099(18)30716-3","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial","volume":"19","author":"Povey","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.07.012_b0155","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2022.07.012_b0160","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1020066806544","article-title":"The incidence of chickenpox in the community","volume":"17","author":"Fleming","year":"2001","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.012_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.21101\/cejph.a3572","article-title":"Evaluation of mandatory case-based reporting system for varicella in the prevaccine era","volume":"18","author":"So\u010dan","year":"2010","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.vaccine.2022.07.012_b0170","doi-asserted-by":"crossref","unstructured":"Bonhoeffer, J, Baer, G, Muehleisen, B, Aebi, C, Nadal, D, Schaad, UB, and Heininger, U. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. European journal of pediatrics, 2005. 164(6): p. 366-370. DOI: 10.1007\/s00431-005-1637-8.","DOI":"10.1007\/s00431-005-1637-8"},{"key":"10.1016\/j.vaccine.2022.07.012_b0175","doi-asserted-by":"crossref","unstructured":"Sierra, W, Argoty, C, and Franco, H. Varicella Incidence Rate Forecasting in Bogot\u00e1 D.C. (Colombia) by Stochastic Time Series Analysis. Applied Computer Sciences in Engineering. WEA 2017. Communications in Computer and Information Science, ed. L.-S.E. Figueroa-Garc\u00eda J., Villa-Ram\u00edrez J., Ferro-Escobar R. Vol. 742. 2017, Cham: Springer. DOI: 10.1007\/978-3-319-66963-2_57.","DOI":"10.1007\/978-3-319-66963-2_57"},{"key":"10.1016\/j.vaccine.2022.07.012_b0180","doi-asserted-by":"crossref","unstructured":"World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014 - recommendations. Vaccine, 2016. 34: p. 198\u2013199. DOI: 10.1016\/j.vaccine.2014.07.068.","DOI":"10.1016\/j.vaccine.2014.07.068"},{"issue":"10299","key":"10.1016\/j.vaccine.2022.07.012_b0185","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0140-6736(21)01337-4","article-title":"Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study","volume":"398","author":"Causey","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.012_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2021-321792","article-title":"Impact of the COVID-19 pandemic on routine childhood immunisation in Colombia","volume":"107","author":"Moreno-Montoya","year":"2022","journal-title":"Arch Dis Child"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:16:11Z","timestamp":1759403771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":38,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22008891"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008\u20132019","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Merck Sharp & Dohme Corp., a subsidiary Merck & Co., Inc., Kenilworth, NJ, USA and The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}